New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
10:26 EDTLRY, INCY, BBRY, LM, CNQ, TGT, MSFT, JNS, CQP, APAM, AYI, BIDU, WLH, STI, M, IRWD, BMY, ANF, ATK, AVY, VTR, QLIKOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Abercrombie & Fitch (ANF) upgraded to Buy from Neutral at Janney Capital... Artisan Partners (APAM) upgraded to Buy from Neutral at Goldman... BlackBerry (BBRY) upgraded to Sector Perform from Underperform at RBC Capital... Bristol-Myers (BMY) upgraded to Overweight from Equal Weight at Barclays... Cheniere Energy Partners LP (CQP) upgraded to Buy from Neutral at Citigroup... Incyte (INCY) upgraded to Overweight from Equal Weight at Barclays... Ironwood (IRWD) upgraded to Outperform from Market Perform at BMO Capital... Janus Capital (JNS) upgraded to Neutral from Sell at Goldman... Liberty Property (LRY) upgraded to Buy from Neutral at UBS... Macy's (M) upgraded to Buy from Neutral at Goldman... Microsoft (MSFT) upgraded to Overweight from Equal Weight at Barclays... Qlik Technologies (QLIK) upgraded to Buy from Hold at Jefferies... SunTrust (STI) upgraded to Conviction Buy from Buy at Goldman... Target (TGT) upgraded to Buy from Neutral at Goldman... Ventas (VTR) upgraded to Buy from Neutral at UBS... William Lyon Homes (WLH) upgraded to Overweight from Neutral at JPMorgan... Canadian Natural (CNQ) upgraded to Outperform from Market Perform at BMO Capital... Avery Dennison (AVY) upgraded at Topeka... Baidu (BIDU) upgraded to Buy from Hold at Maxim... ATK (ATK) upgraded to Buy from Hold at Argus... Legg Mason (LM) upgraded to Neutral from Negative at Susquehanna... Acuity Brands (AYI) upgraded to Neutral from Underperform at Wedbush.
News For ANF;APAM;BBRY;BMY;CQP;INCY;IRWD;JNS;LRY;M;MSFT;QLIK;STI;TGT;VTR;WLH;CNQ;AVY;BIDU;LM;ATK;AYI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
June 23, 2015
07:36 EDTANFJMP Securities to hold a conference
Subscribe for More Information
07:33 EDTBBRYBlackBerry, Cisco sign broad patent cross-licensing agreement
Subscribe for More Information
07:25 EDTINCYPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:13 EDTBBRYBlackBerry up 7.6% after reporting Q1 results
07:06 EDTBBRYBlackBerry CEO says taking steps to make handset business profitable
Subscribe for More Information
07:05 EDTBBRYBlackBerry continues to anticipate positive free cash flow in FY16
Subscribe for More Information
07:05 EDTBBRYBlackBerry recognized hardware revenue on 1.1M smartphones
Subscribe for More Information
07:02 EDTBBRYBlackBerry reports Q1 EPS (5c), consensus (3c)
Subscribe for More Information
06:05 EDTMSFTMicrosoft may charge extra licensing fees for high-end notebooks, DigiTimes says
Subscribe for More Information
06:05 EDTMSFTNo clear prospects for PC component suppliers until July, DigiTimes reports
There are no clear business prospects for PC component suppliers until July, reports DigiTimes. According to sources in the supply chain, Intel's decision to delay the launch of its Skylake platform has weakened market demand for notebooks and other PC systems. The planned release of Microsoft (MSFT) Windows 10 may also affect the production of PC makers. Reference Link
06:04 EDTMSFTOracle says extending enterprise cloud portfolio
At a live event yesterday, Oracle (ORCL) Executive Chairman of the Board and CTO Larry Ellison announced new additions to the Oracle Cloud Platform, a comprehensive, integrated suite of services that make it easier for developers, IT professionals, business users and analysts to build, extend and integrate cloud applications. With more than 24 new cloud services, the Oracle Cloud Platform "extends Oracle's leadership with the world's broadest and deepest portfolio" of SaaS, PaaS and IaaS. Newly available Oracle Cloud services include, Oracle Database Cloud - Exadata, Oracle Archive Storage Cloud, Oracle Big Data Cloud, Oracle Integration Cloud, Oracle Mobile Cloud, and Oracle Process Cloud. The Oracle Cloud Platform helps customers build new applications, extend existing ones, and easily move existing on-premises workloads to the cloud with no application changes. The services are designed to maximize end user experience and productivity; enable developers to manage and analyze data, rapidly develop, test and deploy applications; enable architects to quickly integrate across on-premises and cloud applications; and enable business users to drive rich business insights and enterprise collaboration. With the Oracle Cloud Platform, customers and partners are able to take advantage of the industry-leading Oracle middleware and database software that thousands of global organizations already use to run their own businesses, all delivered via cloud. The extensive level of automation that has been engineered into the Oracle Cloud, results in faster time-to-value, greater innovation, and lower cost for customers. "Oracle is growing really fast. We sold $426M worth of business in SaaS and PaaS last quarter, a 200 percent increase over the same quarter last year. That's an industry record, no company has ever sold that much in just one quarter," said Ellison. "Oracle is the only company on the planet that can deliver a complete, integrated, standards-based suite of services at every layer of the cloud. Those technology advantages enable us to be much more cost-effective than our competitors. Our new Archive Storage service goes head-to-head with Amazon Glacier (AMZN) and it's one-tenth their price."
05:56 EDTMSFT, BBRYEarnings Watch: Analyst says BlackBerry's FY16 targets looking 'unttainable'
Subscribe for More Information
June 22, 2015
15:46 EDTBBRYBlackberry June weekly 9 straddle priced for 7.6% movement into Q1
Subscribe for More Information
15:00 EDTBBRYNotable companies reporting before tomorrow's open
Subscribe for More Information
14:42 EDTMSFTOculus potential not reflected in Facebook's stock price, Piper Jaffray says
Subscribe for More Information
13:00 EDTBBRYBlackberry June weekly volatility elevated into Q1 and outlook
Blackberry June weekly call option implied volatility is at 88, July is at 49, August is at 44; compared to its 52-week range of 34 to 75, suggesting large near term price movement into the expected release of Q1 results on June 23.
11:21 EDTBBRYStocks with call strike movement; TWTR BBRY
Subscribe for More Information
08:52 EDTBMYPortola, Bristol-Myers, and Pfizer announce results from Phase 3 ANNEXA study
Subscribe for More Information
06:09 EDTBIDUHK opens door to Alibaba and others to to return 'home', Financial Times says
Hong Kong's stock exchange has opened the door to Alibaba (BABA) listing on its home market, reports the Financial Times. The xchange said it would re-examine its current bar on China-based companies having a secondary listing of their shares in the city. The move could permit groups like Alibaba, Baidu (BIDU), and JD.com (JD) to return "home" via secondary listings." Reference Link
05:35 EDTBMYAllied-Bristol Life Sciences licenses IP from Harvard University
Allied-Bristol Life Sciences, a biopharmaceutical enterprise jointly owned by Allied Minds and Bristol-Myers Squibb, announced that it has entered into a licensing agreement with Harvard University based on research and intellectual property developed in Professor Malcolm Whitmanís lab at the Harvard School of Dental Medicine. Building on previous studies conducted with Mark Sundrud, PhD, and Anjana Rao, PhD, at Boston Childrenís Hospital, Professor Whitmanís lab, in collaboration with Professor Ralph Mazitschek, PhD, at the Center for Systems Biology at Massachusetts General Hospital, has shown that HF works through inhibition of Prolyl-tRNA synthetase, which leads to activation of an amino acid restriction response pathway. Based on this novel and differentiated mechanism, several lead molecules have been identified by the groups at HMS and MGH that have the potential to lead to effective therapy for several conditions including fibrotic and autoimmune diseases. The licensing agreement with Harvardís Office of Technology Development is among the first in a series of discovery and development projects that Allied-Bristol Life Sciences intends to pursue. The license to the technology from Professor Whitmanís lab will be held by a new ABLS subsidiary specifically formed to pursue further research and pre-clinical development of the technology and associated molecules.
1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use